高盛-艾德生物(300685.SZ):2025年业绩快报显示收入符合预期但净利润好于预期;买入-Amoy Diagnostics(300685.SZ):2025 Preliminary Results Show Revenue in Line with Expectations but Net Profit Beat;Buy-20260313【6页】

发表回复

后才能评论